Hexose-6-phosphate Dehydrogenase Knock-out Mice Lack 11β-Hydroxysteroid Dehydrogenase Type 1-mediated Glucocorticoid Generation
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The local generation of active glucocorticoid by NADPH-dependent, 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) oxoreductase activity, has emerged as an important factor in regulating hepatic glucose output and visceral adiposity. We have proposed that this NADPH is generated within the endoplasmic reticulum by the enzyme hexose-6-phosphate dehydrogenase. To address this hypothesis, we generated mice with a targeted inactivation of the H6PD gene. These mice were unable to convert 11-dehydrocorticosterone (11-DHC) to corticosterone but demonstrated increased corticosterone to 11-DHC conversion consistent with lack of 11beta-HSD1 oxoreductase and a concomitant increase in dehydrogenase activity. This increased corticosterone clearance in the knock-out mice resulted in a reduction in circulating corticosterone levels. Our studies define the critical requirement of hexose-6-phosphate dehydrogenase for 11beta-HSD1 oxoreductase activity and add a new dimension to the investigation of 11beta-HSD1 as a therapeutic target in patients with the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations of H6PDH in patients (594) or knockout of the H6PDH gene in mice (595) appear to be both necessary and sufficient to cause this disorder.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [595]
In the citing paper
“Inactivation of H6PDH in mice and humans leads not only to the loss of 11β-HSD1 oxo-reductase activity but also to a gain of 11β-HSD1 dehydrogenase activity, with a profound switch to cortisol inactivation (4, 12) .”
From Novel H6PDH mutations in two girls with premature adrenarche: ‘apparent’ and ‘true’ CRD can be differentiated by urinary steroid profiling (2013) · cites this paper as [12]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
Self-citationKotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Self-citationMorton, N. M., Holmes, M. C., Fiévet, C., Staels, B., Tailleux, A., Mullins, J. J., & Seckl, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103676200 · Cited by 439
Masuzaki, H., Yamamoto, H., Kenyon, C. J., Elmquist, J. K., Morton, N. M., Paterson, J. M., Shinyama, H., Sharp, M. G. F., Fleming, S., Mullins, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17845 · Cited by 434
Paterson, J. M., Morton, N. M., Fievet, C., Kenyon, C. J., Holmes, M. C., Staels, B., Seckl, J. R., & Mullins, J. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305524101 · Cited by 431
Draper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285
Self-citationAlberts, P., Nilsson, C., Selén, G., Engblom, L. O. M., Edling, N. H. M., Norling, S., Klingström, G., Larsson, C., Forsgren, M., Ashkzari, M., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0344 · Cited by 263
Research works printed but not linked: 1
- White, 1997, Endocr. Rev., 18, 135
Cited by
Items 101–200 of 208
The cross talk of adrenal and Leydig cell steroids in Leydig cells
Wang, Y., Li, H., Zhu, Q., Li, X., Lin, Z., & Ge, R. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105386 · Cited by 32
Differential Modulation of 3T3-L1 Adipogenesis Mediated by 11β-Hydroxysteroid Dehydrogenase-1 Levels
Kim, J., Temple, K. A., Jones, S. A., Meredith, K. N., Basko, J. L., & Brady, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606197200 · Cited by 29
Microglia express functional 11β‐hydroxysteroid dehydrogenase type 1
Gottfried‐Blackmore, A., Sierra, A., Mcewen, B. S., Ge, R., & Bulloch, K. (2010) · Glia · doi:10.1002/glia.21007 · Cited by 27
“Therefore, activity of H6PD and levels of NADPH in activated microglia should be considered, especially as lack of G6PD can abrogate 11bHSD-1 activity (Lavery et al., 2006).”
BackgroundCzegle, I., Csala, M., Mandl, J., Benedetti, A., Karádi, I., & Bánhegyi, G. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i4.129 · Cited by 30
Smit, P., Dekker, M. J. H. J., de Jong, F. J., van den Beld, A. W., Koper, J. W., Pols, H. A. P., Brinkmann, A. O., de Jong, F. H., Breteler, M. M. B., & Lamberts, S. W. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1349 · Cited by 26
Nammi, S., Dembélé, K., & Nyomba, B. L. G. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00255.2006 · Cited by 27
Chia, Y. Y., Liong, S. Y., Ton, S. H., & Kadir, K. B. A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.037 · Cited by 25
The (+)- and (−)-gossypols potently inhibit human and rat 11β-hydroxysteroid dehydrogenase type 2
Chen, B., Lin, H., Hu, G., Su, Y., Zhou, H., Lian, Q., Cai, H., Hardy, D. O., Gu, D., & Ge, R. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.006 · Cited by 26
Balázs, Z., Nashev, L. G., Chandsawangbhuwana, C., Baker, M. E., & Odermatt, A. (2008) · Nature Precedings · doi:10.1016/j.mce.2008.10.021 · Cited by 26
“Importantly, mice lacking H6PDH are unable to convert 11-dehydrocorticosterone to corticosterone (Lavery et al., 2006).”
BackgroundCrosstalk and Barriers Between the Electron Carriers of the Endoplasmic Reticulum
Bánhegyi, G., Margittai, É., Szarka, A., Mandl, J., & Csala, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4437 · Cited by 28
“H6PD is the most important NADPH-generating enzyme in the lumen and has been shown to have a tight functional (3,5,28) and physical (4) connection with 11 b HSD1 (Fig.”
Involvement of GR and p300 in the Induction of H6PD by Cortisol in Human Amnion Fibroblasts
Wang, W., Guo, C., Li, W., Li, J., Wang, W., Myatt, L., & Sun, K. (2012) · Endocrinology · doi:10.1210/en.2012-1531 · Cited by 25
17β-Estradiol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes
Tagawa, N., Yuda, R., Kubota, S., Wakabayashi, M., Yamaguchi, Y., Kiyonaga, D., Mori, N., Minamitani, E., Masuzaki, H., & Kobayashi, Y. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0021 · Cited by 26
“Consistent with this fact, H6PD knockout mice lack 11b-HSD1 activity (Lavery et al. 2006).”
BackgroundLegeza, B., Balázs, Z., Nashev, L. G., & Odermatt, A. (2012) · Endocrinology · doi:10.1210/en.2012-1778 · Cited by 26
Intravascular Glucocorticoid Metabolism during Inflammation and Injury in Mice
Dover, A. R., Hadoke, P. W. F., Macdonald, L. J., Miller, E., Newby, D. E., & Walker, B. R. (2007) · Endocrinology · doi:10.1210/en.2006-0996 · Cited by 22
Ahmed, A., Saksena, S., Sherlock, M., Olliff, S. P., Elias, E., & Stewart, P. M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03125.x · Cited by 24
Self-citationHonda, Y., Ohno, S., & Nakajin, S. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.07.003 · Cited by 25
Biochemistry and physiology of hexose-6-phosphate knockout mice
Zielinska, A. E., Walker, E. A., Stewart, P. M., & Lavery, G. G. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.004 · Cited by 20
Self-citationOh, H., Jeong, K., Han, H. Y., Son, H. J., Kim, S. S., Lee, H. J., Kim, S., Sa, J. H., Jun, H., Ryu, J. H., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.042 · Cited by 20
The metabolism of steroids, toxins and drugs by 11β-hydroxysteroid dehydrogenase 1
Zhou, H.-Y., Hu, G., Lian, Q., Morris, D. J., & Ge, R. (2011) · Toxicology · doi:10.1016/j.tox.2011.11.012 · Cited by 22
Fan, Z., Du, H., Zhang, M., Meng, Z., Chen, L., & Liu, Y. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.010 · Cited by 21
“Furthermore, hepatic 11β-HSD1 reductase activity was impaired in H6PDH knockout mice through inactivation of local NADPH regeneration and these mutant mice exhibited fasting hypoglycemia (Lavery et al., 2006).”
BackgroundMicro RNA ‐661 modulates redox and metabolic homeostasis in colon cancer
de Cedrón, M. G., Acín‐Pérez, R., Sánchez‐Martínez, R., Molina, S., Herránz, J., Feliú, J., Reglero, G., Enríquez, J. A., & de Molina, A. R. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12142 · Cited by 17
“Hexose-6-phosphate dehydrogenase (H6PDH), similar to glucose-6-phosphate dehydrogenase (G6PD), is important for NADPH production and for the global redox homeostasis (Lavery et al., 2006).”
BackgroundResveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes
Tagawa, N., Kubota, S., Kato, I., & Kobayashi, Y. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0066 · Cited by 19
Effects of Obesity and Insulin on Tissue-Specific Recycling Between Cortisol and Cortisone in Men
Anderson, A. J., Andrew, R., Homer, N. Z. M., Hughes, K. A., Boyle, L. D., Nixon, M., Karpe, F., Stimson, R. H., & Walker, B. R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa896 · Cited by 19
Targeting Glucocorticoid Metabolism in Prostate Cancer
Valle, S. R., & Sharifi, N. (2021) · Endocrinology · doi:10.1210/endocr/bqab132 · Cited by 17
2 Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1
Su, X., Vicker, N., & Potter, B. V. L. (2008) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(07)00002-1 · Cited by 18
Fenton, C. G., Crastin, A., Martin, C., Suresh, S., Montagna, I., Hussain, B., Naylor, A. J., Jones, S. W., Hansen, M. S., Gorvin, C. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137334 · Cited by 17
“The GC activating enzyme, 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), activates endogenous and synthetic GC precursors (such as cortisone and prednisone in humans, 11-dehydrocorticosterone (11-DHC) in mice) to their active counterparts (hydrocortisone, prednisolone and corticosterone), amplifying their actions…”
BackgroundSelf-citationPhysiological roles of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase
White, P. C., Rogoff, D., & McMillan, D. R. (2008) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328305e439 · Cited by 16
Self-citationTagawa, N., Kubota, S., Kobayashi, Y., & Kato, I. (2014) · Steroids · doi:10.1016/j.steroids.2014.11.003 · Cited by 18
Prince, P. D., Plantamura, Y. S., Geréz, E. M., Höcht, C., Polizio, A. H., Mayer, M. A., Taira, C. A., Fraga, C. G., Galleano, M., & Carranza, A. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.021 · Cited by 18
Using mass spectrometry imaging to visualize age-related subcellular disruption
Hogan, K. A., Zeidler, J. D., Beasley, H. K., Alsaadi, A. I., Alshaheeb, A. A., Chang, Y., Tian, H., Hinton, A. O., Jr., & McReynolds, M. R. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.906606 · Cited by 16
“…to produce the NADPH needed for steroidogenesis, and H6PD-deficient skeletal muscle exhibits a myopathy characterized by abnormal SR structure (Lavery et al., 2006; Rogoff et al., 2010), activation of stress-induced UPR (Bujalska IJ et al., 2008), and dysregulation of Ca2+ metabolism (Ying,…”
BackgroundThe biological roles of extracellular and intracytoplasmic glucocorticoids in skeletal cells
Hong, D., Chen, H., Ge, R., & Li, J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.06.015 · Cited by 24
Latif, S. A., Shen, M., Ge, R., Sottas, C. M., Hardy, M. P., & Morris, D. J. (2011) · Steroids · doi:10.1016/j.steroids.2011.03.007 · Cited by 16
Specific reduction of G6PT may contribute to downregulation of hepatic 11β-HSD1 in diabetic mice
Du, H., Liu, L., Wang, Y., Nakagawa, Y., Lyzlov, A., Lutfy, K., Friedman, T. C., Peng, X., & Liu, Y. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0223 · Cited by 15
Fujisawa, Y., Nakagawa, Y., Li, R.-S., Liu, Y., & Ohzeki, T. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.07.002 · Cited by 14
Senesi, S., Marcolongo, P., Manini, I., Fulceri, R., Sorrentino, V., Csala, M., Bánhegyi, G., & Benedetti, A. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0028 · Cited by 14
“Moreover, it was found that in H6PD knockout mice, the HSD11B1-mediated prereceptorial glucocorticoid activation was impaired (Lavery et al. 2006).”
BackgroundChedid, M. F., do Nascimento, F. V., de Oliveira, F. S., de Souza, B. M., Kruel, C. D. P., Gurski, R. R., Canani, L. H. S., Crispim, D., & Gerchman, F. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0474-2 · Cited by 14
Biomarkers of hypothalamic–pituitary–adrenal axis activity in mice lacking 11β-HSD1 and H6PDH
Abrahams, L., Semjonous, N. M., Guest, P., Zielinska, A. E., Hughes, B. A., Lavery, G. G., & Stewart, P. M. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0178 · Cited by 18
“Urine samples were collected from male and female mice as described previously (Lavery et al. 2006).”
BackgroundMethodInfluentialSelf-citationWang, Y., Liu, L., Du, H., Nagaoka, Y., Fan, W., Lutfy, K., Friedman, T. C., Jiang, M., & Liu, Y. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00491.2013 · Cited by 15
“Induction of H6PDH expression could enhance intracellular NADPH availability that drives 11ß-HSD1 activity and consequently intracellular GC production that would lead to insulin resistance and hyperglycemia (47, 45, 25).”
BackgroundSakamuri, A., Sakamuri, S. S. V. P., Kona, S. R., Jeyapal, S., & Ibrahim, A. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102082 · Cited by 13
Yan, C., Yang, H., Wang, Y., Dong, Y., Yu, F., Wu, Y., Wang, W., Adaku, U., Lutfy, K., Friedman, T. C., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.57 · Cited by 13
Bakar, M. H. A., Khalid, M. S. F. M., Shahril, N. S. N., Shariff, K. A., & Karunakaran, T. (2021) · BioFactors · doi:10.1002/biof.1793 · Cited by 14
“Consistent with this, diminished 11βHSD1 activity was observed in the H6PDH knockout mice.(64) In agreement with this, we showed that increased H6PDH activities were observed following HFrD supplementation in rats.”
BackgroundSambuceti, G., Cossu, V., Vitale, F., Bianconi, E., Carta, S., Venturi, C. B., Chiesa, S., Lanfranchi, F., Emionite, L., Carlone, S., et al. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04903-z · Cited by 11
“The study included 28 wildtype C57BL/6 J mice (WT) as a control group and 32 littermates, global constitutive knock-out (KO) for the H6PD encoding gene (H6PD −/− ) obtained by inbreeding of animals kindly provided by dr. Lavery, University of Birmingham, UK [18].”
MethodInterplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus
Yao, F., Chen, L., Fan, Z., Teng, F., Zhao, Y., Guan, F., Zhang, M., & Liu, Y. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.07.043 · Cited by 13
Rose, A. M. L., Bazioti, V., Hoogerland, J. A., Svendsen, A. F., Groenen, A. G., van Faassen, M. H. J. R., Rutten, M. G. S., Kloosterhuis, N., Dethmers-Ausema, B., Nijland, J. H., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101265 · Cited by 13
“This is likely the consequence of 11b-HSD1 reductase activity being 20 times higher in mice than in humans [62,64], and may explain why plasma corticosterone is not elevated in L-G6pc / mice in the fed state.”
Background11β-hydroxystéroïde déshydrogénases. Avancées récentes
Vantyghem, M., Marcelli-Tourvieille, S., Defrance, F., & Wémeau, J.-L. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.02.003 · Cited by 13
11β-HSD1 contributes to age-related metabolic decline in male mice
Morgan, S., Gathercole, L., Hassan-Smith, Z. K., Tomlinson, J., Stewart, P. M., & Lavery, G. G. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0169 · Cited by 14
Self-citationMcGee, K. C., Shahmanesh, M., Boothby, M., Nightingale, P., Gathercole, L., Tripathi, G., Harte, A. L., Shojaee‐Moradie, F., Umpleby, A. M., Das, S., et al. (2011) · Antiviral Therapy · doi:10.3851/imp2017 · Cited by 11
“Genes involved in glucocorticoid generation, essential for adipocyte differentiation Genes profiled included 11b-hydroxysteroid dehydrogenase type-1 (11bHSD-1), which regenerates active glucocorticoid cortisol from inactive cortisone [13], hexose 6-phosphate dehydrogenase (H6PDH), which generates the essential cofacto…”
BackgroundXiong, W., Ge, H., Shen, C., Li, C., Zhang, X., Tang, L., Shen, Y., Lu, S., Zhang, H., & Wang, Z. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00918-x · Cited by 11
Sharp, V., Thurston, L. M., Fowkes, R. C., & Michael, A. E. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.03.009 · Cited by 11
McCormick, K. L., Wang, X., & Mick, G. J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.04.003 · Cited by 12
Doig, C. L., Zielinska, A. E., Fletcher, R. S., Oakey, L. A., Elhassan, Y., Garten, A., Cartwright, D., Heising, S., Alsheri, A., Watson, D. G., et al. (2020) · Skeletal Muscle · doi:10.1186/s13395-019-0216-z · Cited by 13
“H6PD NADPH generation supports 11β-HSD1 oxoreductase activity for glucocorticoid production [3].”
BackgroundSelf-citationSoulier, A., Blois, S. M., Sivakumaran, S., Fallah‐Arani, F., Henderson, S. R., Flutter, B. R., Rabbitt, E. H., Stewart, P. M., Lavery, G. G., Bennett, C. L., et al. (2013) · Blood · doi:10.1182/blood-2013-03-489138 · Cited by 12
Self-citationMorita, J., Hakuno, F., Hizuka, N., Takahashi, S., & Takano, K. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-311 · Cited by 12
Wang, D.-Y., Lu, Q., Walsh, S. L., Payne, L. A., Modha, S. S., Scott, M. J., Sweitzer, T. D., Ames, R. S., Krosky, D. J., & Li, H. (2008) · Molecular Biotechnology · doi:10.1007/s12033-008-9050-y · Cited by 10
Weingärtner, M., Stücheli, S., Kratschmar, D. V., Birk, J., Klusoňová, P., Chapman, K. E., Lavery, G. G., & Odermatt, A. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15367 · Cited by 9
Self-citationReciprocal Changes in Maternal and Fetal Metabolism of Corticosterone in Rat During Gestation
Vagnerová, K., Vacková, Z., Klusoňová, P., Štaud, F., Kopecký, M., Ergang, P., Mikšík, I., & Pácha, J. (2008) · Reproductive Sciences · doi:10.1177/1933719108319161 · Cited by 9
“Recent findings show that the activity of 11HSD1 switches from an oxidase to a reductase upon coexpression with the enzyme hexose-6-phosphate dehydrogenase that is thought to modulate the local concentration of nucleotide cosubstrates and is closely associated with 11HSD1 in the membrane of endoplasmic reticulum.(42,4…”
BackgroundMorgan, S., Berryman, D. E., List, E. O., Lavery, G. G., Stewart, P. M., & Kopchick, J. J. (2021) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2021.101440 · Cited by 9
Self-citationGhnenis, A. B., Odhiambo, J. F., Smith, A. M., Pankey, C. L., Nathanielsz, P. W., & Ford, S. P. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174420000112 · Cited by 9
TNFα-mediated Hsd11b1 binding of NF-κB p65 is associated with suppression of 11β-HSD1 in muscle
Doig, C. L., Bashir, J., Zielinska, A. E., Cooper, M. S., Stewart, P. M., & Lavery, G. G. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0494 · Cited by 7
Self-citationJu, R., Wu, W., Tang, Q., Wu, D., Xia, Y., Wu, J., & Wang, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140326 · Cited by 7
“HSD11B1 andH6PD encode 11-beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) and hexose-6-phosphate dehydrogenase (H6PD) and adjust the oxo-reductase activity [15, 16].”
BackgroundCellular and genetic models of H6PDH and 11β‐HSD1 function in skeletal muscle
Zielinska, A. E., Fletcher, R. S., Sherlock, M., Doig, C. L., & Lavery, G. G. (2017) · Cell Biochemistry and Function · doi:10.1002/cbf.3272 · Cited by 9
“Previously, we have shown that 11β‐HSD1 activity in muscle explants of global H6PDHKO mice changes from a reductase to a dehydrogenase.(10,19) We measured these 11β‐HSD1 activities in quadriceps muscle of H6MKO and show a significant loss of oxo‐reductase activity, with a nonsignificant change in dehydrogenase activit…”
BackgroundMethodSelf-citationCharacterization of a Rat Multi-Cell Type 3D-Liver Microtissue System
Odermatt, A. (2013) · Journal of Tissue Science & Engineering · doi:10.4172/2157-7552.1000130 · Cited by 7
“The lowest expression was detected for H6PDH, which was also retained up to day 25 of cultivation.”
BackgroundInfluentialBrossaud, J., Bosch‐Bouju, C., Marissal‐Arvy, N., Campas, M.-N., Helbling, J., Webster, S. P., Walker, B. R., Fioramonti, X., Ferreira, G., Barat, P., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05942-3 · Cited by 7
Contribution of local regeneration of glucocorticoids to tissue steroid pools
Khan, S., Livingstone, D. E. W., Zielinska, A. E., Doig, C. L., Cobice, D., Esteves, C. L., Man, J. T. Y., Homer, N. Z. M., Seckl, J. R., Mackay, C. L., et al. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0034 · Cited by 6
“2018) and by PCR of tail biopsy as described previously in mice lacking H6pdh (Lavery et al. 2006).”
BackgroundSelf-citationErgang, P., Vodička, M., Vagnerová, K., Moravec, M., Kvapilová, P., Kment, M., & Pácha, J. (2017) · Steroids · doi:10.1016/j.steroids.2017.07.007 · Cited by 6
Marbet, P., Klusoňová, P., Birk, J., Kratschmar, D. V., & Odermatt, A. (2018) · FEBS Journal · doi:10.1111/febs.14642 · Cited by 6
PARP Inhibitors: Staying on Target?
Doig, C. L., & Lavery, G. G. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.12.003 · Cited by 7
Self-citationThe life and scientific contributions of Keith L. Parker, 1953–2008
Auchus, R. J., & Wilson, J. D. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.10.015 · Cited by 5
Synergistic Effects of Ageing and Stress on Neutrophil Function
Lord, J. M., Phillips, A. C., & Arlt, W. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_24 · Cited by 6
Foster, C., Mick, G. J., Wang, X., & McCormick, K. L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.001 · Cited by 3
Brossaud, J., Barat, P., & Moisan, M. (2024) · Neuroendocrinology · doi:10.1159/000541989 · Cited by 6
“Given that 11 β -HSD1 activity depends on the cofactor NADPH [148, 152], which is produced by the reduction of NADP + during the fi rst oxidative step of the PPP, it could be hypothesized that hyperglycemia might increase NADPH levels via the PPP, thereby enhancing 11 β -HSD1 activity [147].”
Porzezińska-Furtak, J., Krzyżanowska‐Świniarska, B., Miazgowski, T., Ziemak, J., & Widecka, K. (2009) · Endokrynologia, Otyłość i Zaburzenia Przemiany Materii · Cited by 9
Huang, H., Jing-jiao, Z. E. N. G., Tang, L.-M., Geng, L., Yu, X., Deng, C.-Y., Liu, H., Huang, P. C., Hong, E., & Hu, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38486 · Cited by 2
“Previous studies have shown that in transgenic mice lacking H6PDH, the reductase activity of 11 β -HSD1 decreases, resulting in a predominant dehydrogenase activity [42,43].”
Background11β-Hydroxysteroid Dehydrogenases in the Regulation of Tissue Glucocorticoid Availability
Pereira, C., Monteiro, R., Constância, M., & João, M. (2012) · InTech eBooks · doi:10.5772/53645 · Cited by 3
“Curiously, the co-inheri‐ tance of inactivating mutations in both HSD11B1 and H6PDH (Draper et al., 2003), decreas‐ ing NADPH supply and switching 11β-HSD1 to the dehydrogenase activity (Lavery et al., 2006), may also be in the origin of the syndrome.”
Background11β-Hydroxysteroid Dehydrogenase Type 1 and the Metabolic Syndrome
Cidalia, D., Maria, J., Azevedo, I., & Monteiro, R. (2011) · InTech eBooks · doi:10.5772/28641 · Cited by 2
“In the H6PDH null mouse, hepatic or AT, 11┚-HSD1 acts mainly as a dehydrogenase (Bujalska et al., 2008b; Lavery et al., 2006).”
BackgroundLi, S., Liu, W., Wang, L., Huang, R., Chen, Q., Wu, Y., & Cai, Y. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2010.507288 · Cited by 2
“In vitro, 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) catalyses both reductase and dehydrogenase reaction, whereas in vivo, providing dihydronicotinamide adenine dinuclectide phosphate (NADPH) by hexose-6phosphate dehydrogenase (H6PD), it predominantly acts as a reductase [8,9], catalyses the reduction of inact…”
BackgroundSequence and expression of 11β-hydroxysteroid dehydrogenase type 1 cDNA cloned from pig testis
Ohno, S., Ohta, M., Honda, Y., & Nakajin, S. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0348-2 · Cited by 2
Modulation of glucose and lipid metabolism in adrenalectomised rats given glycyrrhizic acid
Ng, Y. Y. E., Chandramouli, C., Ton, S. H., Kadir, K. A., Haque, F., & Tamotharan, M. (2012) · Journal of Molecular Pathophysiology · doi:10.5455/jmp.20120221113254 · Cited by 2
“H6PDH knock-out mice demonstrated minimal oxo-reductase activities and moderate dehydrogenase activities [27, 62].”
BackgroundMichael, A. E., Thurston, L. M., & Fowkes, R. C. (2019) · Biology · doi:10.3390/biology8040081 · Cited by 2
11β-hydroxysteroid dehydrogenase type 1 : a new therapeutic target post-myocardial infarction?
McSweeney, S. J. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 3
El síndrome metabólico como síndrome de Cushing intrahepatocitario
Vázquez, G. F., Torrecilla, E., & Rubio, M. Á. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.12.003 · Cited by 2
Hao, T., Zhao, X., Ji, Z., Xia, M., Han, L., Sang, J., Wang, S., Li, L., Ge, R., & Zhu, Q. (2024) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2024.109900 · Cited by 1
Sakalauskaite, G., Weingärtner, M., Ebert, S., Boot, G. F., Bock, T., Birk, J., Tsachaki, M., Gallon, J., Piscuoglio, S., & Odermatt, A. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01388-9 · Cited by 2
“Microsomes (20–30 µg of protein in 100 µL) were permeabilized by Triton X-100 (0.5% v/v) for 5 min and incubated with 0.4 mM NADP + and 10 mM H6PD-specific substrate G6S (Glycoteam GmbH, Hamburg, Germany) [49].”
InfluentialTargeting 11β-hydroxysteroid dehydrogenase type 1 in brain: therapy for cognitive aging?
Yau, J. L. W., MacLullich, A. M. J., & Seckl, J. R. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.4.527 · Cited by 2
Redox Imbalance in the Endoplasmic Reticulum
Bánhegyi, G., Margittai, É., Csala, M., & Mandl, J. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8_3 · Cited by 2
Bánhegyi, G., Benedetti, A., & Csala, M. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb152 · Cited by 1
Sunak, N. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Corticosteroid hormone action in the cardiovascular system
Hammer, F. (2011) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Estrogen and Glucocorticoid Metabolism
Andersson, T. (2010) · DiVA at Umeå University (Umeå University)
TALEN Constructs and Validation for Targeting of SETDB1 Genomic DNA
Noh, H.-J., 강윤성, & Kim, K. (2014) · Journal of Life Science · doi:10.5352/jls.2014.24.12.1269
“특히 유 전자를 제거하기 위해서는 genomic DNA 수준에서 상동 재 조합 기법이 이용되거나, 또는 전사된 mRNA 에 결합하는 발 현을 억제하는 miRNA, siRNA 등을 이용한 방법들이 세포 또는 동물 들을 대상으로 이용되고 있다[5, 7].”
11β‐Hydroxysteroid Dehydrogenase Type 1 as a Therapeutic Target for Type 2 Diabetes
Hale, C., & Jean, D. J. S. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch16
Tomlinson, J. (2009) · Clinical Lipidology · doi:10.2217/clp.09.31
Interactions between glucocorticoid metabolism and inflammation in obesity and insulin resistance.
Nixon, M. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Glucocorticoid sensitivity: pathology, mutations and clinical implications
Ray, D. W., Donn, R. P., & Berry, A. A. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.3.403 · Cited by 1
Wang, Y., Liu, L., Du, H., Nagaoka, Y., Fan, W., Friedman, T. C., Jiang, M., Liu, Y., Charles, R., & Jiaotong, S. (2013)
Title of dissertation: HIGH SUCROSE, FRUCTOSE, AND GLUCOSE DIETS AND GLUCOCORTICOID DYSREGULATION IN
London, E., & Castonguay, T. W. (2009)
The metabolic syndrome as intrahepatocytic Cushing's syndrome
Vázquez, G. F., Torrecilla, E., & Rubio, M. Á. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/s2173-5093(11)70039-3
The impact of glucocorticoids upon the insulin sensitivity of skeletal muscle
Morgan, S. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 2
Glucocorticoids as Modulators of Adipose Inflammation
Morton, N. M. (2009) · Oxidative stress and disease · doi:10.1201/9781420091311.ch8
Metadata
- Authors
- Lavery, G. G., Walker, E. A., Draper, N., Jeyasuria, P., Marcos, J., Shackleton, C. H. L., Parker, K. L., White, P. C., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- The University of Texas Southwestern Medical Center (US)
- UCSF Benioff Children's Hospital (US)
- Corresponding author
- Stewart, Paul M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 281
- Issue
- 10
- Pages
- 6546-6551
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2033474018
- Semantic Scholar
- de686e1b3c804228c9bd624505f14d4110b08e9c
- Cited by
- 207
- References
- 30
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 10 · 2012: 15
- FWCI
- 14.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5361 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- hexose-6-phosphate dehydrogenase, 11β-hydroxysteroid dehydrogenase type 1, 11-dehydrocorticosterone, NADPH production, endoplasmic reticulum, hepatic glucose production, visceral fat, metabolic syndrome
- MeSH terms
- Adrenal Glands, Animals, Carbohydrate Dehydrogenases, Female, Glucocorticoids, Kinetics, Male, Mice, Inbred C57BL, Microsomes, Liver, Sequence Deletion, Mice, Knockout, Metabolic Syndrome, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.